1. Home
  2. ALMS vs GFR Comparison

ALMS vs GFR Comparison

Compare ALMS & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • GFR
  • Stock Information
  • Founded
  • ALMS 2021
  • GFR 2018
  • Country
  • ALMS United States
  • GFR Canada
  • Employees
  • ALMS N/A
  • GFR N/A
  • Industry
  • ALMS
  • GFR
  • Sector
  • ALMS
  • GFR
  • Exchange
  • ALMS NYSE
  • GFR Nasdaq
  • Market Cap
  • ALMS 469.0M
  • GFR 489.7M
  • IPO Year
  • ALMS 2024
  • GFR N/A
  • Fundamental
  • Price
  • ALMS $8.82
  • GFR $6.09
  • Analyst Decision
  • ALMS Strong Buy
  • GFR Buy
  • Analyst Count
  • ALMS 6
  • GFR 1
  • Target Price
  • ALMS $29.60
  • GFR $10.50
  • AVG Volume (30 Days)
  • ALMS 148.8K
  • GFR 104.7K
  • Earning Date
  • ALMS 02-15-2025
  • GFR 02-14-2025
  • Dividend Yield
  • ALMS N/A
  • GFR N/A
  • EPS Growth
  • ALMS N/A
  • GFR N/A
  • EPS
  • ALMS N/A
  • GFR 0.40
  • Revenue
  • ALMS N/A
  • GFR $551,353,492.00
  • Revenue This Year
  • ALMS N/A
  • GFR $35.03
  • Revenue Next Year
  • ALMS N/A
  • GFR $37.50
  • P/E Ratio
  • ALMS N/A
  • GFR $15.16
  • Revenue Growth
  • ALMS N/A
  • GFR 11.20
  • 52 Week Low
  • ALMS $7.66
  • GFR $4.68
  • 52 Week High
  • ALMS $13.53
  • GFR $8.16
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • GFR 25.40
  • Support Level
  • ALMS N/A
  • GFR $6.28
  • Resistance Level
  • ALMS N/A
  • GFR $7.33
  • Average True Range (ATR)
  • ALMS 0.00
  • GFR 0.26
  • MACD
  • ALMS 0.00
  • GFR -0.09
  • Stochastic Oscillator
  • ALMS 0.00
  • GFR 8.82

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.

Share on Social Networks: